FDA Approvals Provide Advances for a Range of Cancer Types
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Tag: Prostate cancer
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
Non-Hispanic black men in the United States are much more likely to develop prostate cancer and to die from...
Rates of diabetes in the United States are increasing. According to statistics from the Centers for Disease Control and...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55...
A team of mathematicians are designing an app that could help predict the likelihood of prostate cancer relapse.